Expression Of CD25 Antigen On CD34+Cells Is An Independent Predictor Of Survival In Late Stage MDS Patients Treated With Azacitidine

被引：0
|
作者：
Kotsianidis, Ioannis
Miltiades, Paraskevi
Lamprianidou, Eleftheria
Vassilakopoulos, Theodoros
Papageorgiou, Sotirios G.
Galanopoulos, Athanasios G.
Vakalopoulou, Sofia
Garypidou, Vassilia
Spanoudakis, Emmanouil
Papaioannou, Maria
Hadjiharissi, Evdoxia
Papadaki, Helen A.
Tsatalas, Costas
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1508.1508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1508
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Increased expression of CD25 antigen in lymphocytes and increased number of NK cells are observed in CTCL patients after photopheresis.
    Alcindor, T
    Demierre, MF
    Baki, J
    Gorgun, G
    Urbano, AG
    Foss, FM
    BLOOD, 1999, 94 (10) : 97A - 97A
  • [22] The clonogenic potential of selected CD34+cells from patients with MDS appear preserved when tested ex vivo
    Davison, Glenda Mary
    Novitzky, Nicolas
    Abdulla, Rygana
    LEUKEMIA RESEARCH, 2011, 35 (09) : 1200 - 1204
  • [23] Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells
    Julian Baumeister
    Tiago Maié
    Nicolas Chatain
    Lin Gan
    Barbora Weinbergerova
    Marcelo A. S. de Toledo
    Jörg Eschweiler
    Angela Maurer
    Jiri Mayer
    Blanka Kubesova
    Zdenek Racil
    Andreas Schuppert
    Ivan Costa
    Steffen Koschmieder
    Tim H. Brümmendorf
    Deniz Gezer
    Annals of Hematology, 2021, 100 : 2943 - 2956
  • [24] Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells
    Baumeister, Julian
    Maie, Tiago
    Chatain, Nicolas
    Gan, Lin
    Weinbergerova, Barbora
    de Toledo, Marcelo A. S.
    Eschweiler, Joerg
    Maurer, Angela
    Mayer, Jiri
    Kubesova, Blanka
    Racil, Zdenek
    Schuppert, Andreas
    Costa, Ivan
    Koschmieder, Steffen
    Brummendorf, Tim H.
    Gezer, Deniz
    ANNALS OF HEMATOLOGY, 2021, 100 (12) : 2943 - 2956
  • [25] Expression of the CAMPATH-1 Antigen (CD52) on CD34+/CD38-Progenitor Cells in Patients with 5q-MDS and in a Subset of AML
    Blatt, Katharina
    Herrmann, Harald
    Cerny-Reiterer, Sabine
    Herndlhofer, Susanne
    Sperr, Wolfgang R.
    Valent, Peter
    BLOOD, 2011, 118 (21) : 753 - 753
  • [26] Presence of CD25 antigen on lymphocytes of patients treated for non- small cell lung cancer (NSCLC)
    Rybojad, Pawel
    Tabarkiewicz, Jacek
    Koncewicz, Tomasz
    Gorniewski, Grzegorz
    Rolinski, Jacek
    Gozdziuk, Kazimierz
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2006, 3 (03): : 285 - 289
  • [27] Loss of CD25 Expression in Advanced Systemic Mastocytosis Patients Treated with Midostaurin (PKC412)
    Kunder, C. A.
    Deangelo, D. J.
    Gotlib, J. R.
    Gitana, G.
    Atwater, S. K.
    George, T. I.
    LABORATORY INVESTIGATION, 2012, 92 : 349A - 349A
  • [28] Loss of CD25 Expression in Advanced Systemic Mastocytosis Patients Treated with Midostaurin (PKC412)
    Kunder, C. A.
    Deangelo, D. J.
    Gotlib, J. R.
    Gitana, G.
    Atwater, S. K.
    George, T. I.
    MODERN PATHOLOGY, 2012, 25 : 349A - 349A
  • [29] Molecular profiling of CD34+cells from diagnosis in CML patients identifies low expression of CD7 with high expression of proteinase 3 or elastase as predictors of longer survival
    Yong, ASM
    Szydlo, RM
    Goldman, JM
    Apperley, JF
    Melo, JV
    BLOOD, 2005, 106 (11) : 562A - 562A
  • [30] Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
    Pellagatti, A
    Giagounidis, A
    Killick, S
    Campbell, LJ
    Wraight, V
    Langford, CF
    Fidler, C
    Oscier, D
    Aul, C
    Wainscoat, JS
    Boultwood, J
    BLOOD, 2004, 104 (11) : 649A - 649A
12345